LifeStance Health Group (NASDAQ:LFST) is one of the most promising mid-cap healthcare stocks under $50. On December 12, BTIG analyst David Larsen reiterated his bullish stance on LifeStance Health Group (NASDAQ:LFST). The analyst rated the stock as Buy and raised the price target from $9 to $10 a share. As per Larsen’s forecasts, the stock offers a highly impressive upside potential of around 42% to investors. Oversold Healthcare Stocks to Buy beerkoff/Shutterstock.com The analyst anticipates strong me ...